263 related articles for article (PubMed ID: 2143581)
1. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
Mercer WE; Shields MT; Amin M; Sauve GJ; Appella E; Romano JW; Ullrich SJ
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6166-70. PubMed ID: 2143581
[TBL] [Abstract][Full Text] [Related]
2. Suppression of human colorectal carcinoma cell growth by wild-type p53.
Baker SJ; Markowitz S; Fearon ER; Willson JK; Vogelstein B
Science; 1990 Aug; 249(4971):912-5. PubMed ID: 2144057
[TBL] [Abstract][Full Text] [Related]
3. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.
Lin D; Shields MT; Ullrich SJ; Appella E; Mercer WE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9210-4. PubMed ID: 1409626
[TBL] [Abstract][Full Text] [Related]
4. Wild type human p53 is antiproliferative in SV40-transformed hamster cells.
Mercer WE; Amin M; Sauve GJ; Appella E; Ullrich SJ; Romano JW
Oncogene; 1990 Jul; 5(7):973-80. PubMed ID: 2165234
[TBL] [Abstract][Full Text] [Related]
5. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy.
Asai A; Miyagi Y; Sugiyama A; Gamanuma M; Hong SH; Takamoto S; Nomura K; Matsutani M; Takakura K; Kuchino Y
J Neurooncol; 1994; 19(3):259-68. PubMed ID: 7807177
[TBL] [Abstract][Full Text] [Related]
6. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.
Mercer WE; Shields MT; Lin D; Appella E; Ullrich SJ
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1958-62. PubMed ID: 1705714
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
Goya L; Maiyar AC; Ge Y; Firestone GL
Mol Endocrinol; 1993 Sep; 7(9):1121-32. PubMed ID: 8247014
[TBL] [Abstract][Full Text] [Related]
8. An antisense RNA involved in p53 mRNA maturation in murine erythroleukemia cells induced to differentiate.
Khochbin S; Lawrence JJ
EMBO J; 1989 Dec; 8(13):4107-14. PubMed ID: 2480234
[TBL] [Abstract][Full Text] [Related]
9. Enforced expression of wild-type p53 curtails the transcription of the O(6)-methylguanine-DNA methyltransferase gene in human tumor cells and enhances their sensitivity to alkylating agents.
Srivenugopal KS; Shou J; Mullapudi SR; Lang FF; Rao JS; Ali-Osman F
Clin Cancer Res; 2001 May; 7(5):1398-409. PubMed ID: 11350911
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressive activity of the growth arrest-specific gene GAS1 in human tumor cell lines.
Evdokiou A; Cowled PA
Int J Cancer; 1998 Feb; 75(4):568-77. PubMed ID: 9466658
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of the interferon-inducible protein p202 in NIH 3T3 cells affects cell cycle progression.
Lembo D; Angeretti A; Benefazio S; Hertel L; Gariglio M; Novelli F; Landolfo S
J Biol Regul Homeost Agents; 1995; 9(2):42-6. PubMed ID: 9127631
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
13. Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status.
Zhao S; Tsuchida T; Kawakami K; Shi C; Kawamoto K
Int J Oncol; 2002 Jul; 21(1):49-55. PubMed ID: 12063549
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
[TBL] [Abstract][Full Text] [Related]
15. Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro.
Khalid MH; Shibata S; Hiura T
J Neurosurg; 1999 May; 90(5):918-27. PubMed ID: 10223459
[TBL] [Abstract][Full Text] [Related]
16. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
17. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells.
Ling YH; Zou Y; Perez-Soler R
Anticancer Res; 2000; 20(2A):693-702. PubMed ID: 10810342
[TBL] [Abstract][Full Text] [Related]
18. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.
Bressac B; Galvin KM; Liang TJ; Isselbacher KJ; Wands JR; Ozturk M
Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1973-7. PubMed ID: 2155427
[TBL] [Abstract][Full Text] [Related]
19. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
20. Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53.
Noble JR; Willetts KE; Mercer WE; Reddel RR
Exp Cell Res; 1992 Dec; 203(2):297-304. PubMed ID: 1459195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
